 |
|
Vitromacular Traction Syndrome (VMT)
Vitromacular traction syndrome is a condition where the vitreous (gel that fills the inside cavity of the eye) has an abnormally strong adhesion to the macula (the central vision area of the retina that allows fine detail). This can lead to macular holes or macular edema, which causes decreased or distorted vision. Currently the only treatment available is observation versus surgical Pars Plana Vitrectomy.
Current clinical trial:
Thrombogenics MIVI TRUST
Phase III trial evaluating microplasmin for the non-surgical treatment of vitromacular traction. Microplasmin for intravitreous injection-traction release without surgical treatment program. Microplasmin is given as an intravitreal injection to test the release of VMT without the need for surgery.
Patients that are not candidates for the non-surgical trial are offered minimally invasive, suture-less 23/25-gauge vitrectomy using the most advanced ALCON Constellation vitrectomy system. Dr. Gupta participated on the Retina Advisory Committee that helped to design this exceptional instrumentation for optimum surgical outcomes. Dr. Gupta was honored to co-author an article presenting data on the Constellation Vision System (1 MB) in Retinal Physician.
To explore this section, please choose from the menu on the left.
